Cargando…

Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009

BACKGROUND: The purpose of this study was to investigate the completeness of TNM (Tumor, Node, Metastasis) staging for breast cancer in the Danish Cancer Registry. METHODS: We identified 26,488 patients with a first diagnosis of breast cancer between 2004 and 2009 from the Danish Cancer Registry. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ording, Anne Gulbech, Nielsson, Malene Schou, Frøslev, Trine, Friis, Søren, Garne, Jens Peter, Søgaard, Mette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429150/
https://www.ncbi.nlm.nih.gov/pubmed/22936852
http://dx.doi.org/10.2147/CLEP.S31574
_version_ 1782241775077818368
author Ording, Anne Gulbech
Nielsson, Malene Schou
Frøslev, Trine
Friis, Søren
Garne, Jens Peter
Søgaard, Mette
author_facet Ording, Anne Gulbech
Nielsson, Malene Schou
Frøslev, Trine
Friis, Søren
Garne, Jens Peter
Søgaard, Mette
author_sort Ording, Anne Gulbech
collection PubMed
description BACKGROUND: The purpose of this study was to investigate the completeness of TNM (Tumor, Node, Metastasis) staging for breast cancer in the Danish Cancer Registry. METHODS: We identified 26,488 patients with a first diagnosis of breast cancer between 2004 and 2009 from the Danish Cancer Registry. We obtained information on comorbidity through the Danish National Patient Registry. We estimated the completeness of TNM registration in the Danish Cancer Registry and stratified the analysis by gender, age, year of cancer diagnosis, and comorbidity. We designed an algorithm categorizing breast cancer into localized, regional, distant, or unknown stage based on TNM codes. RESULTS: The overall completeness of TNM registration was 85.4%. The completeness varied little by gender and study year, but decreased from 91.3% in patients aged 0–39 years to 57.0% in patients aged 80 years or more, and from 87.9% among patients with a low level of comorbidity to 69.7% among patients with a high level of comorbidity. CONCLUSION: The completeness of the TNM registration varied substantially by age and level of comorbidity. Thus, depending on the outcome under study, stage-specific analyses may yield biased results. The completeness of TNM should be considered in study designs using TNM information.
format Online
Article
Text
id pubmed-3429150
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-34291502012-08-30 Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009 Ording, Anne Gulbech Nielsson, Malene Schou Frøslev, Trine Friis, Søren Garne, Jens Peter Søgaard, Mette Clin Epidemiol Short Report BACKGROUND: The purpose of this study was to investigate the completeness of TNM (Tumor, Node, Metastasis) staging for breast cancer in the Danish Cancer Registry. METHODS: We identified 26,488 patients with a first diagnosis of breast cancer between 2004 and 2009 from the Danish Cancer Registry. We obtained information on comorbidity through the Danish National Patient Registry. We estimated the completeness of TNM registration in the Danish Cancer Registry and stratified the analysis by gender, age, year of cancer diagnosis, and comorbidity. We designed an algorithm categorizing breast cancer into localized, regional, distant, or unknown stage based on TNM codes. RESULTS: The overall completeness of TNM registration was 85.4%. The completeness varied little by gender and study year, but decreased from 91.3% in patients aged 0–39 years to 57.0% in patients aged 80 years or more, and from 87.9% among patients with a low level of comorbidity to 69.7% among patients with a high level of comorbidity. CONCLUSION: The completeness of the TNM registration varied substantially by age and level of comorbidity. Thus, depending on the outcome under study, stage-specific analyses may yield biased results. The completeness of TNM should be considered in study designs using TNM information. Dove Medical Press 2012-08-17 /pmc/articles/PMC3429150/ /pubmed/22936852 http://dx.doi.org/10.2147/CLEP.S31574 Text en © 2012 Ording et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Short Report
Ording, Anne Gulbech
Nielsson, Malene Schou
Frøslev, Trine
Friis, Søren
Garne, Jens Peter
Søgaard, Mette
Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009
title Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009
title_full Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009
title_fullStr Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009
title_full_unstemmed Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009
title_short Completeness of breast cancer staging in the Danish Cancer Registry, 2004–2009
title_sort completeness of breast cancer staging in the danish cancer registry, 2004–2009
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429150/
https://www.ncbi.nlm.nih.gov/pubmed/22936852
http://dx.doi.org/10.2147/CLEP.S31574
work_keys_str_mv AT ordingannegulbech completenessofbreastcancerstaginginthedanishcancerregistry20042009
AT nielssonmaleneschou completenessofbreastcancerstaginginthedanishcancerregistry20042009
AT frøslevtrine completenessofbreastcancerstaginginthedanishcancerregistry20042009
AT friissøren completenessofbreastcancerstaginginthedanishcancerregistry20042009
AT garnejenspeter completenessofbreastcancerstaginginthedanishcancerregistry20042009
AT søgaardmette completenessofbreastcancerstaginginthedanishcancerregistry20042009